In a world where sight is everything, the race to restore vision is intensifying—and the Retinal Dystrophy Treatment Market is quickly emerging as a key battlefield. Once considered a rare and untreatable group of inherited eye diseases, retinal dystrophy is now at the center of cutting-edge medical innovation. From gene therapy breakthroughs to retinal implants, this market is...